Pericarditis News and Research

RSS

Pericarditis is defined as the state of inflammation or infection of the pericardium, the membranous sac that encloses the heart. The cause and severity of pericarditis determines the type of treatment appropriate for this condition.

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.

17 Sep 2023

ARAMIS trial finds no benefit of anakinra in acute myocarditis

The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

25 Aug 2023

Safety surveillance suggests that COVID-19 mRNA vaccination is safe for young children

Researchers presented the results of their rapid cycle analysis safety surveillance, which is a weekly surveillance monitoring of monovalent mRNA COVID-19 vaccines among all children below five years enrolled in the Vaccine Safety Datalink (VSD).

8 Jun 2023

Review finds no indications of serious side effects of COVID-19 vaccines given to young children

A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children (most of them age 4 and younger) found no indications of serious side effects.

6 Jun 2023

New study finds elevated inflammatory cytokines and lymphocytes linked to rare cases of myocarditis after COVID-19 vaccination

Researchers investigated a cohort of patients who developed myocarditis after SARS-CoV-2 mRNA vaccination.

10 May 2023

Study finds heightened risk of cardiovascular disease among cancer survivors

Cancer survivors may be at long-term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk factors, suggest the findings of a large UK Biobank study, published online in the journal Heart.

19 Apr 2023

Does the incidence of reported myocarditis or pericarditis after BNT162b2 vaccination vary by age, sex, and inter-dose interval among adolescents aged 12 to 17?

Researchers conducted a population-based cohort study among 12 to 17-year-old adolescents in Ontario, Canada, to estimate the incidence of myocarditis or pericarditis after BNT162b2 vaccination.

3 Mar 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

The safety profile of the first and second monovalent and bivalent BNT162b2 mRNA booster vaccines in older adults

Researchers evaluated the safety profiles of booster doses of the monovalent and bivalent mRNA COVID-19 vaccine BNT162b2 in adults above the age of 60.

30 Jan 2023

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

In a recent study posted to medRxiv*, researchers in Denmark examined the risk of adverse events after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron-based bivalent booster vaccination.

24 Jan 2023

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Researchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.

24 Jan 2023

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

Researchers evaluated adverse events in older adults after mRNA vaccination for COVID-19.

24 Jan 2023

What is the association between COVID-19, cardiovascular disease, and mortality?

In a new study, researchers evaluated the association between COVID-19 (coronavirus disease 2019) and CVD (cardiovascular disease) and/or death.

23 Jan 2023

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

A recent Eurosurveillance study focused on estimating the incidence of a prespecified list of adverse events following the first and second doses of the COVID-19 vaccination.

23 Jan 2023

Cardiac MRI of individuals with acute or post-acute COVID-19

In a recent study published in the Journal of Clinical Ultrasound, researchers in Italy reported cardiac magnetic resonance (CMR) findings in individuals with myocarditis-like syndrome during the acute phase of SARS-CoV-2 infection (AMCovS) and post-acute phase (cPACS).

3 Jan 2023

Study provides safety assurance to the global population regarding COVID-19 booster vaccines

In a first-of-its-kind study, researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches and monitored their physiological parameters over two years.

28 Dec 2022

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Researchers modeled the benefit-risk of Moderna’s COVID-19 mRNA-1273 vaccine.

12 Dec 2022

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.

16 Nov 2022

Can monkeypox infection lead to myocarditis?

A recent study presents the first known case of myocarditis as a complication of monkeypox virus infection.

13 Nov 2022

Pericarditis News and Research

Further Reading

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

ARAMIS trial finds no benefit of anakinra in acute myocarditis

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Safety surveillance suggests that COVID-19 mRNA vaccination is safe for young children

Review finds no indications of serious side effects of COVID-19 vaccines given to young children

New study finds elevated inflammatory cytokines and lymphocytes linked to rare cases of myocarditis after COVID-19 vaccination

Study finds heightened risk of cardiovascular disease among cancer survivors

Does the incidence of reported myocarditis or pericarditis after BNT162b2 vaccination vary by age, sex, and inter-dose interval among adolescents aged 12 to 17?

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

The safety profile of the first and second monovalent and bivalent BNT162b2 mRNA booster vaccines in older adults

A new report examines the safety of bivalent COVID boosters among 1.7 million over-50s

New study evaluates the safety profile of the BNT162b2 vaccine in New Zealand

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

What is the association between COVID-19, cardiovascular disease, and mortality?

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

Cardiac MRI of individuals with acute or post-acute COVID-19

Study provides safety assurance to the global population regarding COVID-19 booster vaccines

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

Can monkeypox infection lead to myocarditis?

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News